# USpharma, Ltd., Co. – FDA Inspection, Jun 23, 2022

Source: https://www.keypedia.com/records/fda_inspections/uspharma-ltd-co/0ee76a7c-aa1f-4f24-b92d-d10003c36418
Source feed: FDA_Inspections

> FDA inspection 1172561 of USpharma, Ltd., Co., June 23, 2022. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1172561
- Company Name: USpharma, Ltd., Co.
- Inspection Date: 2022-06-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1334262 - 2026-09-03](https://www.keypedia.com/records/fda_inspections/uspharma-ltd-co/f42c646f-2e75-441f-adb7-44400bb75e06)
- FDA Inspection 1334958 - 2026-09-01
- [FDA Inspection 1205546 - 2023-05-11](https://www.keypedia.com/records/fda_inspections/uspharma-ltd-co/aebff30a-bd8c-4932-a30d-d8f250541cb5)
- FDA Inspection 1198249 - 2023-02-16
- FDA Inspection 912614 - 2015-02-03

Company: https://www.keypedia.com/companies/uspharma-ltd-co/964df153-5c44-460a-949f-69325271a2b1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c